Accolade, Inc. (ACCD)
NASDAQ: ACCD · Real-Time Price · USD
3.608
-0.182 (-4.80%)
Dec 3, 2024, 12:09 PM EST - Market open
Accolade Market Cap
Accolade has a market cap or net worth of $290.59 million as of December 3, 2024. Its market cap has decreased by -51.56% in one year.
Market Cap
290.59M
Enterprise Value
309.69M
1-Year Change
-51.56%
Ranking
Category
Stock Price
$3.61
Market Cap Chart
Since July 2, 2020, Accolade's market cap has decreased from $1.40B to $290.59M, a decrease of -79.31%. That is a compound annual growth rate of -30.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 29, 2024 | 310.87M | -66.05% |
| Dec 29, 2023 | 915.55M | 63.37% |
| Dec 30, 2022 | 560.40M | -68.11% |
| Dec 31, 2021 | 1.76B | -26.60% |
| Dec 31, 2020 | 2.39B | 70.48% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sanara MedTech | 317.65M |
| NeuroPace | 316.39M |
| Valneva SE | 316.07M |
| COMPASS Pathways | 314.39M |
| iTeos Therapeutics | 312.36M |
| Artiva Biotherapeutics | 310.42M |
| Immutep | 307.87M |
| Bright Minds Biosciences | 303.58M |